Help Save Baby Debjani Mukherjee from Blood Cancer
Baby Debjani Mukherjee has been diagnosed with Blood Cancer. Her OPD visit is scheduled on 19th December, and chemotherapy will begin on 20th December.
The Total Estimated Cost : ₹8,00,000
This is a crucial stage of her treatment, and she urgently needs financial assistance to continue her life-saving care. We humbly request all donors and supporters to please come forward and help Baby Debjani during this challenging time. Your support can make a life-saving difference.

Update 22 December 25
As per the latest medical review dated 19 December 2025, Baby Debjani Mukherjee (3 years 11 months) is clinically stable with safe blood counts, despite mild upper respiratory symptoms. Doctors have advised to continue treatment as per protocol.
Upcoming Treatment:
20 December 2025: Vincristine chemotherapy (IV)
26 December 2025: Pediatric OPD visit with blood tests & plasma biobanking
29 December 2025: Intrathecal Methotrexate She is on supportive medications and requires close monitoring for fever or infection during this phase. This consolidation treatment is very important and involves repeated hospital visits and expenses.

Update 27 December 25
Diagnosis: Acute Lymphoblastic Leukemia (ALL)
Baby Debjani Mukherjee is currently receiving treatment for Acute Lymphoblastic Leukemia (ALL) at Tata Medical Center, Kolkata. As per the latest medical review conducted on 26th December 2025, she has successfully completed the first phase of high-risk consolidation chemotherapy (HR-Cons-I). Her current blood reports indicate very low immunity (ANC 0.3). Doctors have therefore advised strict fever precautions and immediate hospital visit if fever develops. At present, she is clinically stable and remains under close medical monitoring. If her blood counts show improvement, the medical team plans to initiate the next phase of chemotherapy (HR-Consolidation Part-2) from 5th January 2026. This phase will include multiple chemotherapy drugs, injections, intrathecal chemotherapy, oral medications, supportive medicines, and regular blood investigations. A pediatric OPD review along with investigations has been scheduled for 3rd January 2026.

TREATMENT COMPLETED
(As per ICICLE-24 Protocol | Update: 3rd January 2026) Baby Debjani visited the Pediatric OPD for evaluation and was found to be clinically stable and active, with no fever or major complaints. Her blood counts had recovered and were within safe limits. Kidney function tests and electrolyte levels were normal.

ONGOING / CURRENT TREATMENT
High-Risk Consolidation – Part 2 (ICICLE-24 Protocol) Phase I – 05 January 2026 Intrathecal Methotrexate administered Cyclophosphamide chemotherapy given Oral 6-Mercaptopurine started (05 January – 18 January 2026) Phase II – 06 to 09 January 2026 Cytarabine injections administered as per protocol Phase III – 09 January 2026 Pediatric OPD follow-up with CBC blood test

FUTURE TREATMENT PLAN
(As Per ICICLE-24 Protocol) I. 13 – 16 January 2026 Second cycle of Cytarabine injections planned II. 20 January 2026 Vincristine chemotherapy PEG-Asparaginase injection (with 60-minute observation) III. 27 January 2026 Next dose of Vincristine chemotherapy IV. 03 February 2026 Plasma biobanking scheduled

Update 8 January 2026
Diagnosis: Acute Lymphoblastic Leukemia (ALL)
Treatment Completed
(As per ICICLE-24 Protocol | 3rd January 2026) Baby Debjani attended a scheduled OPD evaluation and was found to be clinically stable and active, with no fever or major complaints. Her blood counts have recovered and are within safe limits. Kidney function and electrolytes were assessed and found to be normal. Based on this overall assessment, the doctors have cleared her to proceed with the next phase of chemotherapy.
Ongoing / Current Treatment
High-Risk Consolidation – Part 2 (ICICLE-24 Protocol) Phase I – 5th January 2026 Intrathecal Methotrexate administered Cyclophosphamide chemotherapy given Oral 6-Mercaptopurine started (05–18 January 2026) Phase II – 6th to 9th January 2026 Cytarabine injections administered Phase III – 9th January 2026 Pediatric OPD follow-up with CBC blood test
Future Treatment Plan
(As per Protocol) 13th–16th January 2026: Second cycle of Cytarabine injections 20th January 2026: Vincristine chemotherapy and PEG-Asparaginase injection (with 60-minute observation) 27th January 2026: Next dose of Vincristine chemotherapy 3rd February 2026: Plasma biobanking scheduled